Partnering with BI Sincerely, Yours - Boehringer Ingelheim
Partnering with BI Sincerely, Yours - Boehringer Ingelheim
Partnering with BI Sincerely, Yours - Boehringer Ingelheim
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Dr. Laurie Churchill<br />
Global Licensing<br />
Immunology/Inflammation<br />
Ridgefield, CT , USA<br />
Phone: +1 203 798 4632<br />
Fax: +1 203 837 4632<br />
E-mail: laurie.churchill@<br />
boehringer-ingelheim.com<br />
Ms. Karen Devine<br />
Global Licensing<br />
Immunology/Inflammation<br />
Ridgefield, CT USA<br />
Phone: +1 203 798 5745<br />
Fax: +1 203 837 5745<br />
E-mail: karen.devine@<br />
boehringer-ingelheim.com<br />
Despite advances in treatment, there remains a large unmet medical need for safe and efficacious<br />
treatment of autoimmune diseases. Our drug discovery in these therapeutic areas<br />
places an emphasis on gaining a mechanistic understanding of rheumatoid arthritis, multiple<br />
sclerosis and psoriasis.<br />
We have extensive expertise and experience in innovative research, pre-clinical and clinical<br />
development, as well as formulation and production of both small molecule and protein<br />
therapeutics in autoimmune and inflammatory diseases. We are looking for partners who are<br />
aiming as well to fill therapeutic gaps in these areas.<br />
Immunology/Inflammation<br />
Key Areas for <strong>Partnering</strong><br />
• Rheumatoid arthritis<br />
• Psoriasis<br />
• Multiple sclerosis<br />
Additional <strong>Partnering</strong> Interest<br />
• Inflammatory Bowel Disease (Crohn’s<br />
disease, ulcerative colitis)<br />
• Systemic lupus erythematosus<br />
Excluded Areas<br />
• Prophylactic vaccines<br />
• Antisense<br />
• Gene therapy<br />
14 Immunology/Inflammation<br />
15
Change language